Lorcaserin Oral Tablet [Belviq]
RxNorm 1300709
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1300709 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lorcaserin Oral Tablet [Belviq].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDF
Semantic Branded Drug Form (SBDF):
Lorcaserin Oral Tablet [Belviq]
(Atom ID: 4626148)
Patient Education
Lorcaserin
Lorcaserin is used to help adults who are obese or who are overweight and have weight-related medical problems to lose weight and keep from gaining back that weight. Lorcaserin must be used along with a reduced calorie diet and an exercise plan. Lorcaserin is in a class of medications called serotonin receptor agonists. It works by increasing feelings of fullness so that less food is eaten.
[Learn More]
* Please review the disclaimer below.